[HTML][HTML] Regulation of V-ATPase assembly and function of V-ATPases in tumor cell invasiveness

C McGuire, K Cotter, L Stransky, M Forgac - Biochimica et Biophysica Acta …, 2016 - Elsevier
C McGuire, K Cotter, L Stransky, M Forgac
Biochimica et Biophysica Acta (BBA)-Bioenergetics, 2016Elsevier
V-ATPases are ATP-driven proton pumps that function within both intracellular
compartments and the plasma membrane in a wide array of normal physiological and
pathophysiological processes. V-ATPases are composed of a peripheral V 1 domain that
hydrolyzes ATP and an integral V 0 domain that transports protons. Regulated assembly of
the V-ATPase represents an important mechanism of regulating V-ATPase activity in
response to a number of environmental cues. Our laboratory has demonstrated that glucose …
Abstract
V-ATPases are ATP-driven proton pumps that function within both intracellular compartments and the plasma membrane in a wide array of normal physiological and pathophysiological processes. V-ATPases are composed of a peripheral V1 domain that hydrolyzes ATP and an integral V0 domain that transports protons. Regulated assembly of the V-ATPase represents an important mechanism of regulating V-ATPase activity in response to a number of environmental cues. Our laboratory has demonstrated that glucose-dependent assembly of the V-ATPase complex in yeast is controlled by the Ras/cAMP/PKA pathway. By contrast, increased assembly of the V-ATPase during dendritic cell maturation involves the PI-3 kinase and mTORC1 pathways. Recently, we have shown that amino acids regulate V-ATPase assembly in mammalian cells, possibly as a means to maintain adequate levels of amino acids upon nutrient starvation. V-ATPases have also been implicated in cancer cell survival and invasion. V-ATPases are targeted to different cellular membranes by isoforms of subunit a, with a3 targeting V-ATPases to the plasma membrane of osteoclasts. We have shown that highly invasive human breast cancer cell lines express higher levels of the a3 isoform than poorly invasive lines and that knockdown of a3 reduces both expression of V-ATPases at the plasma membrane and in vitro invasion of breast tumor cells. Moreover, overexpression of a3 in a non-invasive breast epithelial line increases both plasma membrane V-ATPases and in vitro invasion. Finally, specific ablation of plasma membrane V-ATPases in highly invasive human breast cancer cells using either an antibody or small molecule approach inhibits both in vitro invasion and migration. These results suggest that plasma membrane and a3-containing V-ATPases represent a novel and important target in the development of therapeutics to limit breast cancer metastasis. This article is part of a Special Issue entitled 'EBEC 2016: 19th European Bioenergetics Conference, Riva del Garda, Italy, July 2-6, 2016', edited by Prof. Paolo Bernardi.
Elsevier